SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis

The oncogenic activity of Hexokinase 2, the first rate-limiting enzyme of glycolysis, requires its mitochondrial localization. Here, the authors show that SUMOylation of hexokinase 2 disrupts its binding to mitochondria and protects cells from tumorigenesis in prostate cancer.

Guardado en:
Detalles Bibliográficos
Autores principales: Xun Shangguan, Jianli He, Zehua Ma, Weiwei zhang, Yiyi Ji, Kai Shen, Zhiying Yue, Wenyu Li, Zhixiang Xin, Quan Zheng, Ying Cao, Jiahua Pan, Baijun Dong, Jinke Cheng, Qi Wang, Wei Xue
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/4e3e924854294e17bd2cd16091505acc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4e3e924854294e17bd2cd16091505acc
record_format dspace
spelling oai:doaj.org-article:4e3e924854294e17bd2cd16091505acc2021-12-02T11:44:50ZSUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis10.1038/s41467-021-22163-72041-1723https://doaj.org/article/4e3e924854294e17bd2cd16091505acc2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-22163-7https://doaj.org/toc/2041-1723The oncogenic activity of Hexokinase 2, the first rate-limiting enzyme of glycolysis, requires its mitochondrial localization. Here, the authors show that SUMOylation of hexokinase 2 disrupts its binding to mitochondria and protects cells from tumorigenesis in prostate cancer.Xun ShangguanJianli HeZehua MaWeiwei zhangYiyi JiKai ShenZhiying YueWenyu LiZhixiang XinQuan ZhengYing CaoJiahua PanBaijun DongJinke ChengQi WangWei XueNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Xun Shangguan
Jianli He
Zehua Ma
Weiwei zhang
Yiyi Ji
Kai Shen
Zhiying Yue
Wenyu Li
Zhixiang Xin
Quan Zheng
Ying Cao
Jiahua Pan
Baijun Dong
Jinke Cheng
Qi Wang
Wei Xue
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
description The oncogenic activity of Hexokinase 2, the first rate-limiting enzyme of glycolysis, requires its mitochondrial localization. Here, the authors show that SUMOylation of hexokinase 2 disrupts its binding to mitochondria and protects cells from tumorigenesis in prostate cancer.
format article
author Xun Shangguan
Jianli He
Zehua Ma
Weiwei zhang
Yiyi Ji
Kai Shen
Zhiying Yue
Wenyu Li
Zhixiang Xin
Quan Zheng
Ying Cao
Jiahua Pan
Baijun Dong
Jinke Cheng
Qi Wang
Wei Xue
author_facet Xun Shangguan
Jianli He
Zehua Ma
Weiwei zhang
Yiyi Ji
Kai Shen
Zhiying Yue
Wenyu Li
Zhixiang Xin
Quan Zheng
Ying Cao
Jiahua Pan
Baijun Dong
Jinke Cheng
Qi Wang
Wei Xue
author_sort Xun Shangguan
title SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
title_short SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
title_full SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
title_fullStr SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
title_full_unstemmed SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
title_sort sumoylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4e3e924854294e17bd2cd16091505acc
work_keys_str_mv AT xunshangguan sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT jianlihe sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT zehuama sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT weiweizhang sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT yiyiji sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT kaishen sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT zhiyingyue sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT wenyuli sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT zhixiangxin sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT quanzheng sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT yingcao sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT jiahuapan sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT baijundong sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT jinkecheng sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT qiwang sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
AT weixue sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis
_version_ 1718395279336538112